Indeed, numerous studies have shown that pro-oxidant agents can increase the production of Aβ [43], [44], and a recent report has revealed that antioxidant therapy interrupts the progression of amyloid and tau pathology in a mouse model of AD [45]. The gene discussed is MAPT; the disease is Alzheimer disease.